1. Home
  2. GVA vs APGE Comparison

GVA vs APGE Comparison

Compare GVA & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Granite Construction Incorporated

GVA

Granite Construction Incorporated

HOLD

Current Price

$116.14

Market Cap

4.5B

Sector

Industrials

ML Signal

HOLD

Logo Apogee Therapeutics Inc.

APGE

Apogee Therapeutics Inc.

HOLD

Current Price

$77.16

Market Cap

4.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GVA
APGE
Founded
1922
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.5B
4.7B
IPO Year
1990
2023

Fundamental Metrics

Financial Performance
Metric
GVA
APGE
Price
$116.14
$77.16
Analyst Decision
Hold
Strong Buy
Analyst Count
3
8
Target Price
$105.00
$100.00
AVG Volume (30 Days)
634.1K
818.6K
Earning Date
11-06-2025
11-10-2025
Dividend Yield
0.45%
N/A
EPS Growth
68.53
N/A
EPS
3.67
N/A
Revenue
$4,236,312,000.00
N/A
Revenue This Year
$11.29
N/A
Revenue Next Year
$10.61
N/A
P/E Ratio
$31.38
N/A
Revenue Growth
6.87
N/A
52 Week Low
$69.08
$26.20
52 Week High
$115.88
$78.12

Technical Indicators

Market Signals
Indicator
GVA
APGE
Relative Strength Index (RSI) 79.75 73.47
Support Level $107.77 $74.48
Resistance Level $110.31 $76.87
Average True Range (ATR) 2.43 3.37
MACD 1.04 -0.06
Stochastic Oscillator 89.23 91.13

Price Performance

Historical Comparison
GVA
APGE

About GVA Granite Construction Incorporated

Granite Construction Inc engages in the construction and development of various infrastructure projects on behalf of public and private clients in the United States. It focuses on heavy civil infrastructure projects, including roads, highways, transit facilities, airports, bridges, and other infrastructure projects. In addition, the company performs site preparation and infrastructure services for residential development, energy development, and other facilities. The majority of revenue is derived from the company's Construction operating segment, with the remainder derived from its Materials segment.

About APGE Apogee Therapeutics Inc.

Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

Share on Social Networks: